Injecting into the suprachoroidal space (SCS) is increasingly popular. What pearls can you learn from Robert L. Avery, MD, who recently published a paper alongside other members of a panel examining best practices for SCS injections? Join him and host…
By Andrew Beers, Associate Editor H ospitals have their advantages and disadvantages. Ambulatory surgery centers do as well. But how about office-based surgery and its…
A 61-year-old woman with recently diagnosed lung adenocarcinoma presented with rapid vision loss in her left eye. Ophthalmoscopy revealed an elevated white-yellow retinal mass (A),…
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Volume 8 Issue 4 p327-426, e9-e14 Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If…
This video highlights the AI Eye and Smart Cane, innovative assistive devices designed to help visually impaired individuals navigate their surroundings with…
Volume 132 Issue 8 p853-960, e1-e152 Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If…
Can’t sign in? Forgot your username? Can’t sign in? Forgot your password? The corresponding author is Kourous A. Rezaei at Ophthalmic Surgery, Lasers and Imaging…
In recent years, the issue of correcting higher-order aberrations has become increasingly relevant, particularly in patients who have undergone surgery such as keratotomy or keratoplasty…
Amid conference organizers’ efforts to promote diversity, David Lockington proposes a simple way to make sure more voices are truly heard
Included in the agreement are ranibizumab-nuna 0.05 mL injection (BYOOVIZ), referencing LUCENTIS (ranibizumab), and aflibercept-yszy 0.05 mL injection (OPUVIZ), referencing EYLEA (aflibercept).
